About Jointown

About Jointown

Group Profile

More
As a technology-driven comprehensive service provider for the whole chain pharmaceutical industry, Jointown is based on the comprehensive health industry. Its main business comprises the following six parts: digital pharmaceutical distribution and supply chain business, general agency brand promotion business, pharmaceutical industrial self-production and OEM business, new retail and Ten-Thousand Store Alliance Plan business (C-end), medical health (C-end) and technology value-added services, and digital logistics technology and supply chain solutions.

In the future, Jointown will continue to promote the comprehensive service model of "pharmaceutical distribution + logistics distribution + product promotion", follow the emerging trends in the market and take actions accordingly to maintain a robust growth.
billion RMB
Operating Income in 2023
million RMB
R&D Investment in 2023
%
CAGR in Recent 10 Years
th
Top 500 Chinese Enterprises

Corporate Strategy

New Products
More
Jointown acquires ownership, franchise and sales dominance of products in form of ownership, agent and OEM, with product and promotion marketing system to enhance capabilities to promote new products and profitability of the company.Focusing on Chinese and Western patent medicines, Jointown has organized and coordinated Jingfeng Pharmaceutical, product strategic development sector, All Ways Engine, general agency grand promotion group-medical channels, pharmaceutical service sector, and central marketing sector to enhance Jointown product competitiveness in respective business areas from the three dimensions of R&D, production, and promotion.
New Retail
More
Jointown has empowered Ten-thousand Store Alliance with advanced technologies, enhanced digitalization of franchised stores, reshaped the ecosystem, and constructed service system combining integration of wholesale and retail, BC integration, and online and offline services, to create new values and experience for B-end and C-end customers.The New Retail strategy covers transformation in six aspects: digitalization of franchised pharmacies, full-network e-commerce agency operation services for pharmaceutical and medical device enterprises, platform-based B2B business in single pharmacies and clinics, intelligent medical services, logistics integration of “wholesale and retail & warehousing and distribution,” and convenient financing settlement. Jointown has set this strategy to realize in-depth comprehensive digitalization focused on Jointown core business, and build a closed loop of retail service system.
New Medical Services
More
Based on Jointown supply chain, the company has consolidated specialized disease services, online operation, insurance services, etc., constructed operation system for clinics, and has created the brand “JiuXin Clinics”, striving to build the most professional service platform combining clinic supply chain services, operational services, and medical services, Based on the supply chain business, Jointown has optimized variety structure in clinics, constructed dedicated supply system for relative varieties, and improved variety coverage for clinics; Jointown has set up professional team to provide digital and intelligent operational value-added services for clinics, promoted ten-thousand clinics alliance providing one-stop solutions, so as to enhance business growth in clinics, Through consolidating diverse capabilities such as specialized disease services, online services, and health insurance, Jointown has expanded and upgraded digital medical service step by step, from supply chain services to a comprehensive clinic service platform integrating supply chain and centering on digital medical services.
Digitalization
More
Jointown aims to further utilize AI technology and carry out intelligent applications through digitalization of multiple scenarios such as business, management, and services for upstream and downstream customers, so as to enhance operation and management with less cost and higher efficiency, and create greater value for customers. In this way, Jointown will improve experience of internal and external customers, and promote operation quality and efficiency.
Real Estate Securitization
More
Jointown has promoted the issuance of public REITs and the first phase of Pre-REITs, in order to revitalize the huge warehousing and logistics assets and supporting facilities, reconstruct its asset-light business model, realize the dual-cycle of capital and asset operation, broaden financing channels for diversified equity to achieve rapid growth of company business.Relying on the linked resources of the listed platform of Jointown in the pharmaceutical industry, the company strives to build up a first-class real estate management platform among the pharmaceutical industry in China, with the unique project acquisition capability and the industry-leading asset operation capability.

Group Leadership

More
Board Of Directors
More
Board Of Supervisors
More
Management Team
More

Development History

undefined undefined
undefined
2019
2020
2021
2022
2023

Corporate Honors

More
No. 15 of Top 100 Chinese Private Service Enterprises in 2023 Fortune
No. 57 of Top 500 Chinese Private Enterprises in 2023 Fortune
Outstanding ESG Practice Enterprise Development Pharmaceutical and Healthcare Company in 2023 Thinking Finance and www.investor.org.cn
ESG Best Practice Enterprise in Social Responsibility in 2022 China Finance and Economy (CFE)
Typical Case of Digital Economy Development (Transformation Category) in 2023 - Integration of Bb/Bc Warehousing and Distribution Digital Economy Leader Forum
2023 First Hubei Charity Award - Caring Donation Enterprise Hubei Provincial People's Government

About Jointown

About Jointown

Group Profile

More
As a technology-driven comprehensive service provider for the whole chain pharmaceutical industry, Jointown is based on the comprehensive health industry. Its main business comprises the following six parts: digital pharmaceutical distribution and supply chain business, general agency brand promotion business, pharmaceutical industrial self-production and OEM business, new retail and Ten-Thousand Store Alliance Plan business (C-end), medical health (C-end) and technology value-added services, and digital logistics technology and supply chain solutions.

In the future, Jointown will continue to promote the comprehensive service model of "pharmaceutical distribution + logistics distribution + product promotion", follow the emerging trends in the market and take actions accordingly to maintain a robust growth.
billion RMB
Operating Income in 2023
million RMB
R&D Investment in 2023
%
CAGR in Recent 10 Years
th
Top 500 Chinese Enterprises

Corporate Strategy

New Products
Jointown acquires ownership, franchise and sales dominance of products in form of ownership, agent and OEM, with product and promotion marketing system to enhance capabilities to promote new products and profitability of the company.Focusing on Chinese and Western patent medicines, Jointown has organized and coordinated Jingfeng Pharmaceutical, product strategic development sector, All Ways Engine, general agency grand promotion group-medical channels, pharmaceutical service sector, and central marketing sector to enhance Jointown product competitiveness in respective business areas from the three dimensions of R&D, production, and promotion.
More
New Retail
Jointown has empowered Ten-thousand Store Alliance with advanced technologies, enhanced digitalization of franchised stores, reshaped the ecosystem, and constructed service system combining integration of wholesale and retail, BC integration, and online and offline services, to create new values and experience for B-end and C-end customers.The New Retail strategy covers transformation in six aspects: digitalization of franchised pharmacies, full-network e-commerce agency operation services for pharmaceutical and medical device enterprises, platform-based B2B business in single pharmacies and clinics, intelligent medical services, logistics integration of “wholesale and retail & warehousing and distribution,” and convenient financing settlement. Jointown has set this strategy to realize in-depth comprehensive digitalization focused on Jointown core business, and build a closed loop of retail service system.
More
New Medical Services
Based on Jointown supply chain, the company has consolidated specialized disease services, online operation, insurance services, etc., constructed operation system for clinics, and has created the brand “JiuXin Clinics”, striving to build the most professional service platform combining clinic supply chain services, operational services, and medical services, Based on the supply chain business, Jointown has optimized variety structure in clinics, constructed dedicated supply system for relative varieties, and improved variety coverage for clinics; Jointown has set up professional team to provide digital and intelligent operational value-added services for clinics, promoted ten-thousand clinics alliance providing one-stop solutions, so as to enhance business growth in clinics, Through consolidating diverse capabilities such as specialized disease services, online services, and health insurance, Jointown has expanded and upgraded digital medical service step by step, from supply chain services to a comprehensive clinic service platform integrating supply chain and centering on digital medical services.
More
Digitalization
Jointown aims to further utilize AI technology and carry out intelligent applications through digitalization of multiple scenarios such as business, management, and services for upstream and downstream customers, so as to enhance operation and management with less cost and higher efficiency, and create greater value for customers. In this way, Jointown will improve experience of internal and external customers, and promote operation quality and efficiency.
More
Real Estate Securitization
Jointown has promoted the issuance of public REITs and the first phase of Pre-REITs, in order to revitalize the huge warehousing and logistics assets and supporting facilities, reconstruct its asset-light business model, realize the dual-cycle of capital and asset operation, broaden financing channels for diversified equity to achieve rapid growth of company business.Relying on the linked resources of the listed platform of Jointown in the pharmaceutical industry, the company strives to build up a first-class real estate management platform among the pharmaceutical industry in China, with the unique project acquisition capability and the industry-leading asset operation capability.
More

Group Leadership

More
Board Of Directors
Board Of Supervisors
Management Team

Development History

2022 2023
Steady Development Jointown continued to accelerate digital transformation and implement six digital initiatives with a total of over 18,800 stores under the Ten-Thousand Store Alliance Plan. The Company participated in and played a leading role in the operation of Jointown's pharmaceutical supply chain companies, and promoted the vigorous development of Wuhan's pharmaceutical comprehensive health industry.

Corporate Honors

More
No. 15 of Top 100 Chinese Private Service Enterprises in 2023 Fortune
No. 57 of Top 500 Chinese Private Enterprises in 2023 Fortune
Outstanding ESG Practice Enterprise Development Pharmaceutical and Healthcare Company in 2023 Thinking Finance and www.investor.org.cn
ESG Best Practice Enterprise in Social Responsibility in 2022 China Finance and Economy (CFE)
Typical Case of Digital Economy Development (Transformation Category) in 2023 - Integration of Bb/Bc Warehousing and Distribution Digital Economy Leader Forum
2023 First Hubei Charity Award - Caring Donation Enterprise Hubei Provincial People's Government